Contagion&reg Editorial Staff

Monica Mahoney, PharmD, BCPS-AQ ID, explains the first-line empiric therapy for candidemia.

Ciara Kennedy, PhD, breaks down APX001, a new antifungal with a unique mechanism of action.

Magda Opsomer, MD, reveals who will benefit from the darunavir single-tablet HIV regimen.

Stay up-to-date on the latest infectious disease news by checking out our top 5 articles of the week.

Jessica Justman, MD, shares how the PHIA project is collecting HIV biomarkers in children.

Amanda Paschke, MD, MSCE, explains the advantage of administering a beta-lactam in combination with a beta-lactamase inhibitor.

Evelyn J. Ellis-Grosse, PhD, chief scientific officer of Zavante Therapeutics, explains why Zavante Therapeutic’s fosfomycin is a unique, novel antimicrobial.

Christopher McCoy, PharmD, shares the protocol for approaching patients who may have a beta-lactam allergy.

Sue Cammarata, MD, explains the advantages that delafloxcin has over other fluoroquinolones.

Neil Fishman, MD, explains what the standardized antimicrobial administration ratio is.

Emily Heil, PharmD, BCPS-AQ ID, sheds light on one of the standards of new antibiotic stewardship regulations: all antibiotic orders should include indication for use.

David Andes, MD, shares the half-life and dosing intervals for a new long-acting echinocandin.

In case you missed them, we've compiled the top five infectious disease articles from this past week.

Steven Gelone, PharmD, shares the topline data yielded from the LEAP-1 study.

David Huang, PhD, MD, shares the recent results of the REVIVE-2 trial.

Patrick Horn, MD, PhD, explains why eravacycline is a unique antibiotic and how it stands up against many different types of pathogens, including those that are multidrug-resistant.

James S. Lewis, PharmD, FIDSA, addresses the issues that surround current antibiotic development.

Viviane Boaventura, MD, MsC, PhD, explains how Zika virus causes auditory loss.

News about the Zika virus dominated our top articles for the month of September 2017. Did you read them all?

William Schaffner, MD, medical director for the National Foundation for Infectious Diseases’ (NFID), provides a brief overview of the past flu season (2016-2017).

As investigators learn a possible explanation for why the Zika virus causes such devastating effects, the CDC has deactivated their emergency operations center for the infection.

New data reveal that when pregnant women receive the Tdap vaccine during pregnancy, it can prevent whooping cough in about 78% of newborns; however, only about 50% of pregnant women receive the vaccine.

Alan Gross, PharmD, explains how a neural network can help identify patients who are at increased risk for multidrug-resistant pathogens.

Silvia Munoz-Price, MD, PhD, explains why infection control bundles should evolve as the problems faced by hospital epidemiologists continue to change.

Stay up-to-date on the latest infectious disease news by checking out our top 5 articles of the week.

Alex Rinehart, PhD, explains how the development of a long-acting injectable offers a new preventive option for HIV.

David A. Schwartz, MD, MS Hyg, FCAP, explains how researchers from all over the world have come together to share their research on Zika virus.

MNT occurs neonatally when a newborn’s unhealed umbilical stump is infected with Clostridium tetani, the bacterium that causes tetanus.

Silvio Pitlik, MD, provides insight into the prevalence of Lyme disease in Israel.

Prof. Francisco Veas, PhD, chief security officer, Institut de Recherche pour le Développement, France, explains some of the issues faced by patients with Lyme disease living in Europe.